The third type of Corona vaccine may be soon available in India. Serum Institute of India's CEO Adar Poonawala said that, Company has applied for trials of Covovax, a vaccine of Novavax. In a tweet he said that Covovax may be launched by June 2021 in Country.<br />''<br />''As per the statement shared by Novovax, Covovax has shown the efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom.<br />''<br />''The study assessed efficacy during a period with high transmission and with a new UK variant strain of the virus emerging and circulating widely. It was conducted in partnership with the UK Government's Vaccines Taskforce.  <br />''<br />''Novavax also announced successful results of its Phase 2b study conducted in South Africa.<br />''<br />''<br />''<span style="color: #222222;">Stanley C. Erck, President and Chief Executive Officer of Novavax says, it is the first vaccine to demonstrate not only high clinical efficacy against COVID-19 but also significant clinical efficacy against both the rapidly emerging UK and South Africa variants.</span><br />